New Diagnostic Tools Aim to Improve Detection of Canine Mast Cell Tumors
Mast cell tumors remain one of the most frequently diagnosed cancers in dogs—and one of the most challenging to identify early. Often appearing as ordinary skin masses, they can be difficult to distinguish from benign lesions without further testing, which can delay diagnosis and treatment decisions.
This Silent Killer Has a Smell and Dogs Can Find It Before Vets Can
Cancer remains one of the leading causes of death in both people and pets. In dogs alone, studies suggest that up to half will develop cancer during their lifetime. Among the most devastating diagnoses is hemangiosarcoma, an aggressive cancer of blood vessel cells that often goes undetected until it is too late.
Breakthrough in Canine Hemangiosarcoma Research: A Genetic Link to Immune System Disruption
Researchers at the University of Florida College of Veterinary Medicine and the UF Health Cancer Center have uncovered a critical connection between a specific gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could pave the way for improved treatments for both dogs and humans with similar cancers.
FDA Renews Canalevia-CA1 for Chemotherapy Induced Diarrhea in Dogs Through 2026
Chemotherapy can be life saving for canine cancer patients, but anyone who has managed a dog with chemotherapy induced diarrhea knows how quickly GI side effects can derail treatment plans, stress pet parents, and drain clinic morale. That is why Jaguar Health’s latest news is worth your attention. The FDA has officially renewed the conditional approval of Canalevia-CA1, extending access to this targeted therapy for chemotherapy induced diarrhea in dogs through December 21, 2026.
Palliative Chemotherapy Shows Promise for Feline Carcinoma of Unknown Primary
Carcinoma of unknown primary, or CUP, is one of those diagnoses that makes even seasoned veterinary professionals pause. Despite advanced imaging, histopathology, and immunohistochemistry, the original tumor site remains elusive. In human oncology, CUP is relatively common and notoriously challenging, accounting for a notable percentage of new cancer diagnoses and carrying a guarded prognosis. In veterinary medicine, especially in cats, documented cases are few, leaving clinicians with limited guidance and a lot of tough conversations.
Altered microRNA Profiles and Associated Pathways in Canine Mammary Adenocarcinoma
Canine mammary tumors remain one of the most common neoplastic diagnoses in intact female dogs, and they continue to challenge clinicians with their biological diversity and unpredictable behavior. Among these tumors, mammary gland adenocarcinoma stands out for its aggressive nature and clinical relevance. Beyond their impact on canine health, these tumors also offer a powerful comparative model for human breast cancer. A recent study exploring microRNA expression in canine mammary adenocarcinoma adds a fresh molecular layer to this conversation and it is surprisingly relatable to what we already know from human oncology.